From: Breast conserving therapy for central breast cancer in the United States
Non-BCT | BCT | P-value | |||
---|---|---|---|---|---|
No | % | No | % | ||
Year of diagnosis | < 0.001 | ||||
2010 | 478 | 17.30 | 420 | 15.20 | |
2011 | 420 | 15.20 | 426 | 15.50 | |
2012 | 500 | 18.10 | 436 | 15.80 | |
2013 | 480 | 17.40 | 437 | 15.90 | |
2014 | 442 | 16.00 | 483 | 17.50 | |
2015 | 437 | 15.90 | 555 | 20.10 | |
Age | 0.114 | ||||
< 45 | 233 | 8.50 | 244 | 8.90 | |
45–59 | 1035 | 37.50 | 1101 | 39.90 | |
60–79 | 1489 | 54.00 | 1412 | 51.20 | |
Race | 0.527 | ||||
White | 2202 | 79.90 | 2169 | 78.70 | |
Black | 254 | 9.20 | 274 | 9.90 | |
Others | 301 | 10.90 | 314 | 11.40 | |
Marital | 0.287 | ||||
Married | 1713 | 62.10 | 1671 | 60.60 | |
Single | 405 | 14.70 | 446 | 16.20 | |
Divorced | 639 | 23.20 | 640 | 23.20 | |
Grade | 0.669 | ||||
Grade I | 585 | 21.20 | 569 | 20.60 | |
Grade II | 1360 | 49.30 | 1406 | 51.00 | |
Grade III | 805 | 29.20 | 775 | 28.10 | |
Grade IV | 7 | 0.30 | 7 | 0.30 | |
T stage | 0.722 | ||||
T1 | 1692 | 61.40 | 1676 | 60.80 | |
T2 | 918 | 33.30 | 948 | 34.40 | |
T3 | 85 | 3.10 | 79 | 2.90 | |
T4 | 62 | 2.20 | 54 | 2.00 | |
N stage | 0.547 | ||||
N0 | 1760 | 63.80 | 1799 | 65.30 | |
N1 | 843 | 30.60 | 815 | 29.60 | |
N2 | 108 | 3.90 | 107 | 3.90 | |
N3 | 46 | 1.70 | 36 | 1.30 | |
ER status | 0.579 | ||||
Negative | 375 | 13.60 | 360 | 13.10 | |
Positive | 2382 | 86.40 | 2397 | 86.90 | |
PR status | 0.409 | ||||
Negative | 636 | 23.10 | 662 | 24.00 | |
Positive | 2121 | 76.90 | 2095 | 76.00 | |
HER-2 status | 0.458 | ||||
Negative | 2316 | 84.00 | 2337 | 84.80 | |
Positive | 441 | 16.00 | 420 | 15.20 |